Traeger, Inc. (COOK): Nasdaq/NYSE listing notice — Traeger receives NYSE non-compliance notice for stock price below $1.00; six-month cure period

Traeger, Inc.

NYSE notice due to average closing price < $1.00 over 30 trading days ended Nov 14, 2025.
Company has six months to cure; considering reverse stock split subject to board and shareholder approval.
Project Gravity expected to deliver ~$50M in annualized run-rate savings; liquidity of $167M as of Sep 30, 2025.
No immediate impact on listing or trading; stock remains listed on NYSE during cure period.
Notice does not affect business operations, SEC reporting, or trigger debt covenant violations.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Traeger, Inc. received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

Exchange: nyse
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 802.01C

Exact text from the filing

lure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On Novembe r 19, 2025 , Traeger, Inc. (the “Company”) received written notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that it is not in compliance with the continued listing standard set forth in Section 802.01C of the NYSE’s Listed Company Manual (“Section 802.01C”) because the average closing price of the Company’s common stock was less than $1.00 per share over a consecutive 30 trading-day period ended November 14, 2025. The Notice does not result in the immediate delisting of the Company’s commo

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Traeger, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-25-053796

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.